This month, The Journal of Clinical Endocrinology & Metabolism is publishing “Appropriate Use of Telehealth Visits in Endocrinology: Perspective Statement of the Endocrine Society.” Since this new modality is here to stay, Endocrine News talks to the authors about which patients are better candidates for telehealth than others, why endocrinology seems tailor-made for this new...
Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. Here is part 2 of Endocrine News’s closer look at some of the endocrine science innovations announced throughout 2021. Endocrine researchers and clinicians continued to remain at the forefront of medical research, the result of which...
Americans diagnosed with hypothyroidism and their clinical providers now have access to greater dosage flexibility within levothyroxine therapy, with three new dosage strengths of levothyroxine sodium oral solution now available to treat hypothyroidism. IBSA Pharma markets the drug as Tirosint®-SOL. The unique new dosing options – 37.5, 44 and 62.5 micrograms – are a first...
HealthPartners Institute’s International Diabetes Center (IDC) recently developed and piloted a process for incorporating patients’ continuous glucose monitoring (CGM) data directly into the electronic health record (EHR), improving clinician access to glucose information. During a presentation at the American Diabetes Association’s 81st Scientific Sessions, IDC medical director Amy Criego, MD, described this process for integrating...
Imposter syndrome – the belief that you do not belong or that you are not good enough – is more common that people think, especially in the medical field. Endocrine News spoke to experts on this dilemma who discuss common solutions to get past these feelings of self-doubt. Some of the most well-known and...
The U.S. Food and Drug Administration this week cleared Abbott’s FreeStyle® Libre 2 iOS application for use with compatible iPhones, to pair with its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system. Approved for adults and children (4 and older) with diabetes, the new app enables users to get glucose readings directly on their...
[Editor’s Note: This post has been updated to include comments from Rita Kalyani, MD.] When the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product last month, many were hailing this as a breakthrough in treating diabetes. The impacts could be immediately felt by people rationing their insulin due to cost as...
Teamwork is often vital to improving patient outcomes. And while most healthcare professionals are in favor of working together, the biggest obstacle appears to be simply finding the time to team up. In a survey conducted last summer by the market research and analytics company The Harris Poll for Boehringer Ingelheim and Eli Lilly and...
This month, The Journal of Clinical Endocrinology & Metabolism is publishing “Appropriate Use of Telehealth Visits in Endocrinology: Perspective Statement of the Endocrine Society.” Since this new modality is here to stay, Endocrine News talks to the authors about which patients are better candidates for telehealth than others, why endocrinology seems tailor-made for this new...
Endocrine research remains at the forefront of medical breakthroughs, which has led to cutting-edge treatment options, therapies, and products. Here is part 2 of Endocrine News’s closer look at some of the endocrine science innovations announced throughout 2021. Endocrine researchers and clinicians continued to remain at the forefront of medical research, the result of which...
The U.S. Food and Drug Administration this week cleared Abbott’s FreeStyle® Libre 2 iOS application for use with compatible iPhones, to pair with its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system. Approved for adults and children (4 and older) with diabetes, the new app enables users to get glucose readings directly on their...
